Explore how patient-derived 3D models and multiomics analyses can help investigate drug response, resistance mechanisms, and precision oncology approaches.
| 1 min read
Creating more sustainable laboratories depends on practical changes that strengthen scientific performance while reducing environmental impact.
| 1 min read
Philip Wills, Chief Commercial Officer of the Cell & Gene Therapy Division at Catalent, reflects on how the gene therapy industry is evolving from early scientific breakthroughs to commercial maturity.Video
| 1 min read
Discover why mass photometry is becoming essential in the toolbox of protein studies.
| 1 min read
Advances in analytical instrumentation are helping researchers study drug behavior, improve biomedical research, and train the next generation of scientists.
| 4 min read
Living drugs are blurring the line between therapy and biology, challenging decades of assumptions about how medicines are made and controlled.
| 2 min read
As the Advanced Therapies sector matures, London brought together global executives, start-ups, and researchers to confront the practical realities of scaling cell and gene therapies
| 1 min read
As omics research expands in scale and complexity, advances in mass spectrometry are helping scientists generate deeper, more reliable insights across proteomics, lipidomics, and metabolomics.
| 1 min read
Find out how advanced tissue imaging approaches are enabling researchers to connect complex biological data with clinically meaningful outcomes.
| 1 min read
Can animal testing be replaced? Discover how scientists are developing more human-relevant ways to predict drug toxicity earlier.
| 1 min read
As drug discovery grows more complex, the pace of discovery increasingly depends on the tools and people working behind the scenes.
| 1 min read
Laboratories account for a surprising share of global emissions and plastic waste, making sustainability a priority for modern research.
